BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 8842585)

  • 21. Characteristics and experiences of American women electing for early removal of contraceptive implants.
    Frank ML; Ditmore JR; Ilegbodu AE; Bateman L; Poindexter AN
    Contraception; 1995 Sep; 52(3):159-65. PubMed ID: 7587187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary experience with Norplant in an inner city population.
    Cullins VE; Blumenthal PD; Remsburg RE; Huggins GR
    Contraception; 1993 Feb; 47(2):193-203. PubMed ID: 8449019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use.
    Kaewrudee S; Taneepanichskul S; Jaisamraun U; Reinprayoon D
    Contraception; 1999 Jul; 60(1):25-30. PubMed ID: 10549449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial angiogenic response in Norplant users.
    Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD; Taylor RN; Klaisle C; Bottles K; Zaloudek C
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A longitudinal study of changes in endometrial microvascular density in Norplant implant users.
    Hickey M; Simbar M; Young L; Markham R; Russell P; Fraser IS
    Contraception; 1999 Feb; 59(2):123-9. PubMed ID: 10361627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of Norplant implants for fertility regulation in Singapore.
    Singh K; Viegas OA; Fong YF; Ratnam SS
    Contraception; 1992 Jan; 45(1):39-47. PubMed ID: 1591920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
    Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
    Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with elective Norplant removal in black and white women.
    Opara JU; Ernst FA; Gaskin H; Smith L; Nevels HV
    J Natl Med Assoc; 1997 Apr; 89(4):237-40. PubMed ID: 9145628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
    Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B
    Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NORPLANT contraceptive implants advancing.
    Segal SJ
    Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability of Norplant-2 rods as a method of family planning.
    Singh K; Viegas OA; Ratnam SS
    Contraception; 1992 May; 45(5):453-61. PubMed ID: 1623717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM; Evans CB; Kim MH
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial vasculature in Norplant users.
    Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():45-50. PubMed ID: 8982745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings.
    Fraser IS; Weisberg E; Minehan E; Johansson ED
    Contraception; 2000 Apr; 61(4):241-51. PubMed ID: 10899479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norplant contraceptive implants: rods versus capsules.
    Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
    Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.